Loading…
Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells
Urokinase-type plasminogen activator (u-PA) plays a key role in malignant tumor behavior. We have previously shown that the expression of high levels of u-PA mRNA in human hepatocellular carcinoma (HCC) biopsies was inversely correlated with the survival of the patients. In order to evaluate the inv...
Saved in:
Published in: | Cancer Gene Therapy 2003-02, Vol.10 (2), p.112-120 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683 |
---|---|
cites | cdi_FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683 |
container_end_page | 120 |
container_issue | 2 |
container_start_page | 112 |
container_title | Cancer Gene Therapy |
container_volume | 10 |
creator | Tavian, Daniela Salvi, Alessandro De Petro, Giuseppina Barlati, Sergio |
description | Urokinase-type plasminogen activator (u-PA) plays a key role in malignant tumor behavior. We have previously shown that the expression of high levels of u-PA mRNA in human hepatocellular carcinoma (HCC) biopsies was inversely correlated with the survival of the patients. In order to evaluate the involvement of u-PA in the invasive and infiltrating properties of HCC cells, the SKHep1C3 cell line was stably transfected with an expression vector containing the 5′ portion (257 bp) of u-PA cDNA in the antisense orientation. u-PA mRNA expression and its protein level and enzymatic activity were specifically inhibited in the antisense transfectants. A comparable inhibition of the u-PA receptor (u-PAR) mRNA and protein was also evidenced in the antisense transfected cells compared with the control ones. At the functional level, the SKHep1C3-AS cells showed a significant reduction in proliferation, Matrigel invasion, and motility assays compared to parental and vector-alone cells. These results indicate that u-PA is an essential factor in the growth and invasiveness of human hepatocarcinoma cells. Antisense u-PA strategy might be a potential approach to reduce tumor growth as well as the invasive capacity of the malignant cells in HCC. |
doi_str_mv | 10.1038/sj.cgt.7700533 |
format | article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_nature_primary_7700533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A182767910</galeid><sourcerecordid>A182767910</sourcerecordid><originalsourceid>FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683</originalsourceid><addsrcrecordid>eNqNkk2P0zAQhiMEYkvhyg0ULdLe0rVjJ7aP1YovaQUSH2dr4tqNS2IX20Fw4L_jqF0KaFdCPtiaed7XM5opiqcYrTAi_DLuVmqbVowh1BByr1hgytqqIRzfLxZI1KLCApGz4lGMO4RykpGHxRmuG9JiIRbFz48JukGX-vs-6Bitd6U3Jbhko3ZRl1PwX6yD_Bo_vFuX1vW2symWqdflPvjBGh0gzTJwm5z-Bjce_TSCK3u9h-SVHoZpgFAqCMo6P0I5h-Lj4oGBIeonx3tZfH718tPVm-r6_eu3V-vrSjWMpQqAkRoQZ6hBjEBdGxBdhwk1bbdBvMW1wYY2hkKDOOWaEwZ0IwxVimrVcrIsLg6-ueSvk45JjjbOFYDTfoqS1aLl9D9AzBlrBaYZfPEPuPNTcLkJWbcUM9QKVmfq_E4KM8op4_xktYVBS-uMTwHU_K9cY16zlok86mWxuoXKZ6NHq7zTxub4X4KLPwS9hiH10Q_TPKx4q7MKPsagjdwHO0L4ITGS85LJuJN5yeRxybLg-bGrqRv15oQftyoDlwcg5pTb6nBq-07LZweFgzQF_dvyJv8Lkbzl4A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>217484788</pqid></control><display><type>article</type><title>Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells</title><source>Wiley-Blackwell Read & Publish Collection</source><source>PubMed Central</source><creator>Tavian, Daniela ; Salvi, Alessandro ; De Petro, Giuseppina ; Barlati, Sergio</creator><creatorcontrib>Tavian, Daniela ; Salvi, Alessandro ; De Petro, Giuseppina ; Barlati, Sergio</creatorcontrib><description>Urokinase-type plasminogen activator (u-PA) plays a key role in malignant tumor behavior. We have previously shown that the expression of high levels of u-PA mRNA in human hepatocellular carcinoma (HCC) biopsies was inversely correlated with the survival of the patients. In order to evaluate the involvement of u-PA in the invasive and infiltrating properties of HCC cells, the SKHep1C3 cell line was stably transfected with an expression vector containing the 5′ portion (257 bp) of u-PA cDNA in the antisense orientation. u-PA mRNA expression and its protein level and enzymatic activity were specifically inhibited in the antisense transfectants. A comparable inhibition of the u-PA receptor (u-PAR) mRNA and protein was also evidenced in the antisense transfected cells compared with the control ones. At the functional level, the SKHep1C3-AS cells showed a significant reduction in proliferation, Matrigel invasion, and motility assays compared to parental and vector-alone cells. These results indicate that u-PA is an essential factor in the growth and invasiveness of human hepatocarcinoma cells. Antisense u-PA strategy might be a potential approach to reduce tumor growth as well as the invasive capacity of the malignant cells in HCC.</description><identifier>ISSN: 0929-1903</identifier><identifier>EISSN: 1476-5381</identifier><identifier>EISSN: 1476-5500</identifier><identifier>DOI: 10.1038/sj.cgt.7700533</identifier><identifier>PMID: 12536199</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Antisense DNA ; Antisense RNA ; Biomedical and Life Sciences ; Biomedicine ; Biopsy ; Cancer cells ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - therapy ; Cell Division - drug effects ; Cell Division - genetics ; Cell Movement - genetics ; Cell proliferation ; Enzymatic activity ; Fluorescent Antibody Technique ; Gene Expression ; Gene Therapy ; Genetic aspects ; Genetic Therapy - methods ; Health aspects ; Hepatocellular carcinoma ; Hepatoma ; Humans ; Immunoblotting ; Invasiveness ; Liver cancer ; Liver Neoplasms - genetics ; Liver Neoplasms - pathology ; Liver Neoplasms - therapy ; Neoplasm Invasiveness ; original-article ; Polymerase Chain Reaction - methods ; Prevention ; Properties ; Receptors, Cell Surface - genetics ; Receptors, Cell Surface - metabolism ; Receptors, Urokinase Plasminogen Activator ; RNA, Antisense - biosynthesis ; RNA, Antisense - genetics ; RNA, Antisense - pharmacology ; RNA, Messenger - biosynthesis ; RNA, Messenger - genetics ; RNA, Messenger - pharmacology ; Transfection ; Tumor Cells, Cultured ; Tumors ; U-Plasminogen activator ; Urokinase ; Urokinase-Type Plasminogen Activator - antagonists & inhibitors ; Urokinase-Type Plasminogen Activator - genetics ; Urokinase-Type Plasminogen Activator - metabolism</subject><ispartof>Cancer Gene Therapy, 2003-02, Vol.10 (2), p.112-120</ispartof><rights>Springer Nature America, Inc. 2003</rights><rights>COPYRIGHT 2003 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Feb 2003</rights><rights>Nature Publishing Group 2003.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683</citedby><cites>FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12536199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tavian, Daniela</creatorcontrib><creatorcontrib>Salvi, Alessandro</creatorcontrib><creatorcontrib>De Petro, Giuseppina</creatorcontrib><creatorcontrib>Barlati, Sergio</creatorcontrib><title>Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells</title><title>Cancer Gene Therapy</title><addtitle>Cancer Gene Ther</addtitle><addtitle>Cancer Gene Ther</addtitle><description>Urokinase-type plasminogen activator (u-PA) plays a key role in malignant tumor behavior. We have previously shown that the expression of high levels of u-PA mRNA in human hepatocellular carcinoma (HCC) biopsies was inversely correlated with the survival of the patients. In order to evaluate the involvement of u-PA in the invasive and infiltrating properties of HCC cells, the SKHep1C3 cell line was stably transfected with an expression vector containing the 5′ portion (257 bp) of u-PA cDNA in the antisense orientation. u-PA mRNA expression and its protein level and enzymatic activity were specifically inhibited in the antisense transfectants. A comparable inhibition of the u-PA receptor (u-PAR) mRNA and protein was also evidenced in the antisense transfected cells compared with the control ones. At the functional level, the SKHep1C3-AS cells showed a significant reduction in proliferation, Matrigel invasion, and motility assays compared to parental and vector-alone cells. These results indicate that u-PA is an essential factor in the growth and invasiveness of human hepatocarcinoma cells. Antisense u-PA strategy might be a potential approach to reduce tumor growth as well as the invasive capacity of the malignant cells in HCC.</description><subject>Antisense DNA</subject><subject>Antisense RNA</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Biopsy</subject><subject>Cancer cells</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - therapy</subject><subject>Cell Division - drug effects</subject><subject>Cell Division - genetics</subject><subject>Cell Movement - genetics</subject><subject>Cell proliferation</subject><subject>Enzymatic activity</subject><subject>Fluorescent Antibody Technique</subject><subject>Gene Expression</subject><subject>Gene Therapy</subject><subject>Genetic aspects</subject><subject>Genetic Therapy - methods</subject><subject>Health aspects</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Humans</subject><subject>Immunoblotting</subject><subject>Invasiveness</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - therapy</subject><subject>Neoplasm Invasiveness</subject><subject>original-article</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Prevention</subject><subject>Properties</subject><subject>Receptors, Cell Surface - genetics</subject><subject>Receptors, Cell Surface - metabolism</subject><subject>Receptors, Urokinase Plasminogen Activator</subject><subject>RNA, Antisense - biosynthesis</subject><subject>RNA, Antisense - genetics</subject><subject>RNA, Antisense - pharmacology</subject><subject>RNA, Messenger - biosynthesis</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - pharmacology</subject><subject>Transfection</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>U-Plasminogen activator</subject><subject>Urokinase</subject><subject>Urokinase-Type Plasminogen Activator - antagonists & inhibitors</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><subject>Urokinase-Type Plasminogen Activator - metabolism</subject><issn>0929-1903</issn><issn>1476-5381</issn><issn>1476-5500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqNkk2P0zAQhiMEYkvhyg0ULdLe0rVjJ7aP1YovaQUSH2dr4tqNS2IX20Fw4L_jqF0KaFdCPtiaed7XM5opiqcYrTAi_DLuVmqbVowh1BByr1hgytqqIRzfLxZI1KLCApGz4lGMO4RykpGHxRmuG9JiIRbFz48JukGX-vs-6Bitd6U3Jbhko3ZRl1PwX6yD_Bo_vFuX1vW2symWqdflPvjBGh0gzTJwm5z-Bjce_TSCK3u9h-SVHoZpgFAqCMo6P0I5h-Lj4oGBIeonx3tZfH718tPVm-r6_eu3V-vrSjWMpQqAkRoQZ6hBjEBdGxBdhwk1bbdBvMW1wYY2hkKDOOWaEwZ0IwxVimrVcrIsLg6-ueSvk45JjjbOFYDTfoqS1aLl9D9AzBlrBaYZfPEPuPNTcLkJWbcUM9QKVmfq_E4KM8op4_xktYVBS-uMTwHU_K9cY16zlok86mWxuoXKZ6NHq7zTxub4X4KLPwS9hiH10Q_TPKx4q7MKPsagjdwHO0L4ITGS85LJuJN5yeRxybLg-bGrqRv15oQftyoDlwcg5pTb6nBq-07LZweFgzQF_dvyJv8Lkbzl4A</recordid><startdate>200302</startdate><enddate>200302</enddate><creator>Tavian, Daniela</creator><creator>Salvi, Alessandro</creator><creator>De Petro, Giuseppina</creator><creator>Barlati, Sergio</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>200302</creationdate><title>Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells</title><author>Tavian, Daniela ; Salvi, Alessandro ; De Petro, Giuseppina ; Barlati, Sergio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antisense DNA</topic><topic>Antisense RNA</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Biopsy</topic><topic>Cancer cells</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - therapy</topic><topic>Cell Division - drug effects</topic><topic>Cell Division - genetics</topic><topic>Cell Movement - genetics</topic><topic>Cell proliferation</topic><topic>Enzymatic activity</topic><topic>Fluorescent Antibody Technique</topic><topic>Gene Expression</topic><topic>Gene Therapy</topic><topic>Genetic aspects</topic><topic>Genetic Therapy - methods</topic><topic>Health aspects</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Humans</topic><topic>Immunoblotting</topic><topic>Invasiveness</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - therapy</topic><topic>Neoplasm Invasiveness</topic><topic>original-article</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Prevention</topic><topic>Properties</topic><topic>Receptors, Cell Surface - genetics</topic><topic>Receptors, Cell Surface - metabolism</topic><topic>Receptors, Urokinase Plasminogen Activator</topic><topic>RNA, Antisense - biosynthesis</topic><topic>RNA, Antisense - genetics</topic><topic>RNA, Antisense - pharmacology</topic><topic>RNA, Messenger - biosynthesis</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - pharmacology</topic><topic>Transfection</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>U-Plasminogen activator</topic><topic>Urokinase</topic><topic>Urokinase-Type Plasminogen Activator - antagonists & inhibitors</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><topic>Urokinase-Type Plasminogen Activator - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tavian, Daniela</creatorcontrib><creatorcontrib>Salvi, Alessandro</creatorcontrib><creatorcontrib>De Petro, Giuseppina</creatorcontrib><creatorcontrib>Barlati, Sergio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biological Sciences</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer Gene Therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tavian, Daniela</au><au>Salvi, Alessandro</au><au>De Petro, Giuseppina</au><au>Barlati, Sergio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells</atitle><jtitle>Cancer Gene Therapy</jtitle><stitle>Cancer Gene Ther</stitle><addtitle>Cancer Gene Ther</addtitle><date>2003-02</date><risdate>2003</risdate><volume>10</volume><issue>2</issue><spage>112</spage><epage>120</epage><pages>112-120</pages><issn>0929-1903</issn><eissn>1476-5381</eissn><eissn>1476-5500</eissn><abstract>Urokinase-type plasminogen activator (u-PA) plays a key role in malignant tumor behavior. We have previously shown that the expression of high levels of u-PA mRNA in human hepatocellular carcinoma (HCC) biopsies was inversely correlated with the survival of the patients. In order to evaluate the involvement of u-PA in the invasive and infiltrating properties of HCC cells, the SKHep1C3 cell line was stably transfected with an expression vector containing the 5′ portion (257 bp) of u-PA cDNA in the antisense orientation. u-PA mRNA expression and its protein level and enzymatic activity were specifically inhibited in the antisense transfectants. A comparable inhibition of the u-PA receptor (u-PAR) mRNA and protein was also evidenced in the antisense transfected cells compared with the control ones. At the functional level, the SKHep1C3-AS cells showed a significant reduction in proliferation, Matrigel invasion, and motility assays compared to parental and vector-alone cells. These results indicate that u-PA is an essential factor in the growth and invasiveness of human hepatocarcinoma cells. Antisense u-PA strategy might be a potential approach to reduce tumor growth as well as the invasive capacity of the malignant cells in HCC.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>12536199</pmid><doi>10.1038/sj.cgt.7700533</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0929-1903 |
ispartof | Cancer Gene Therapy, 2003-02, Vol.10 (2), p.112-120 |
issn | 0929-1903 1476-5381 1476-5500 |
language | eng |
recordid | cdi_nature_primary_7700533 |
source | Wiley-Blackwell Read & Publish Collection; PubMed Central |
subjects | Antisense DNA Antisense RNA Biomedical and Life Sciences Biomedicine Biopsy Cancer cells Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - therapy Cell Division - drug effects Cell Division - genetics Cell Movement - genetics Cell proliferation Enzymatic activity Fluorescent Antibody Technique Gene Expression Gene Therapy Genetic aspects Genetic Therapy - methods Health aspects Hepatocellular carcinoma Hepatoma Humans Immunoblotting Invasiveness Liver cancer Liver Neoplasms - genetics Liver Neoplasms - pathology Liver Neoplasms - therapy Neoplasm Invasiveness original-article Polymerase Chain Reaction - methods Prevention Properties Receptors, Cell Surface - genetics Receptors, Cell Surface - metabolism Receptors, Urokinase Plasminogen Activator RNA, Antisense - biosynthesis RNA, Antisense - genetics RNA, Antisense - pharmacology RNA, Messenger - biosynthesis RNA, Messenger - genetics RNA, Messenger - pharmacology Transfection Tumor Cells, Cultured Tumors U-Plasminogen activator Urokinase Urokinase-Type Plasminogen Activator - antagonists & inhibitors Urokinase-Type Plasminogen Activator - genetics Urokinase-Type Plasminogen Activator - metabolism |
title | Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T21%3A44%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stable%20expression%20of%20antisense%20urokinase%20mRNA%20inhibits%20the%20proliferation%20and%20invasion%20of%20human%20hepatocellular%20carcinoma%20cells&rft.jtitle=Cancer%20Gene%20Therapy&rft.au=Tavian,%20Daniela&rft.date=2003-02&rft.volume=10&rft.issue=2&rft.spage=112&rft.epage=120&rft.pages=112-120&rft.issn=0929-1903&rft.eissn=1476-5381&rft_id=info:doi/10.1038/sj.cgt.7700533&rft_dat=%3Cgale_proqu%3EA182767910%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c577t-aa732a08705073a22fa9bb134f6bd08612f1f45f4a50848e837a4d9f4cc4ec683%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=217484788&rft_id=info:pmid/12536199&rft_galeid=A182767910&rfr_iscdi=true |